收藏切换
Research progress of tumor endocrine therapy drugs
收藏切换
Cong RUAN1, Huan LI2, Qing ZHAI1, 2, 3, *, Rui XU1, Qiong DU1, 2, 3, Jiajia QIAN1
World Clinical Drug | 2022, 43(1) : 80 - 86
Less
收藏切换
World Clinical Drug | 2022, 43(1): 80-86
• Review •
Research progress of tumor endocrine therapy drugs
Full
Cong RUAN1, Huan LI2, Qing ZHAI1, 2, 3, *, Rui XU1, Qiong DU1, 2, 3, Jiajia QIAN1
Affiliations
  • 1.Pharmacy Department, Minhang Branch of Fudan University Cancer Hospital, Shanghai 200240, China
  • 2.Pharmacy Department, Fudan University Cancer Hospital, Shanghai 200032, China
  • 3.Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China
Published: 2022-01-10 doi: 10.13683/j.wph.2022.01.015
Outline
收藏切换

Endocrine drug is widely used to treat hormone-dependent tumors, including breast cancer, prostate cancer and neuroendocrine tumors. Compared with conventional chemotherapy, it not only avoids toxic reactions, but also reduces the occurrence of adverse reactions. Use of endocrine drug treatment to prolong the survival time of patients can also improve the compliance and quality of life of patients, which can not be ignored in the tumor treatment. This article reviewed the pharmacological mechanism, indications and adverse reaction of endocrine drugs currently on the market and approved for the treatment of tumor, in order to provide reference for clinical application of endoocrine drugs.

endocrine drugs  /  estrogen  /  breast cancer  /  prostate cancer  /  neuroendocrine tumor
阮聪, 李焕, 翟青, 徐蕊, 杜琼, 钱佳佳. 肿瘤内分泌治疗药物的研究进展. 世界临床药物, 2022 , 43 (1) : 80 -86 . DOI: 10.13683/j.wph.2022.01.015
Cong RUAN, Huan LI, Qing ZHAI, Rui XU, Qiong DU, Jiajia QIAN. Research progress of tumor endocrine therapy drugs[J]. World Clinical Drug, 2022 , 43 (1) : 80 -86 . DOI: 10.13683/j.wph.2022.01.015
Year 2022 volume 43 Issue 1
13
3
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2022.01.015
  • Receive Date:2021-05-17
  • Online Date:2026-11-19
  • Published:2022-01-10
Article Data
Affiliations
History
  • Received:2021-05-17
  • Revised:2021-12-01
Funding
Affiliations
    1.Pharmacy Department, Minhang Branch of Fudan University Cancer Hospital, Shanghai 200240, China
    2.Pharmacy Department, Fudan University Cancer Hospital, Shanghai 200032, China
    3.Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2022.01.015
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT